The Oncology Institute, Inc. (NASDAQ:TOI) Director Acquires $94,184.48 in Stock
The Oncology Institute, Inc. (NASDAQ:TOI – Get Free Report) Director Mark L. Pacala purchased 90,562 shares of the stock in a transaction dated Wednesday, March 26th. The stock was purchased at an average price of $1.04 per share, for a total transaction of $94,184.48. Following the completion of the acquisition, the director now directly owns […]
-logo-1200x675.png?v=20220303080937&w=240&h=240&zc=2){kind=logo}
The Oncology Institute, Inc. (NASDAQ:TOI – Get Free Report) Director Mark L. Pacala purchased 90,562 shares of the stock in a transaction dated Wednesday, March 26th. The stock was purchased at an average price of $1.04 per share, for a total transaction of $94,184.48. Following the completion of the acquisition, the director now directly owns […]
